Knight Capital Group’s ONYX PHARMACEUTICALS INC ONXX Stock Holding History

Knight Capital Group’s Portfolio ONXX Stock Details ONXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$1.51M	Buy	+17,347	New	+$1.6M	0.03%	714

Other funds holding ONXX

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Knight Capital Group's ONXX Position: Q2 2013 in Review

Knight Capital Group opened a new position in ONYX PHARMACEUTICALS INC (ONXX) in Q2 2013: 17,347 shares worth $1.51M. The stake represents 0.03% of the portfolio and ranks #714 among its holdings.

272 funds tracked by Wall St. Rank hold ONXX as of Q2 2013.

Knight Capital Group held 17,347 shares of ONYX PHARMACEUTICALS INC worth $1.51M as of Q2 2013.
ONYX PHARMACEUTICALS INC was a new Knight Capital Group position in Q2 2013.
ONYX PHARMACEUTICALS INC made up 0.03% of Knight Capital Group's portfolio in Q2 2013, its #714 holding.
272 funds tracked by Wall St. Rank held ONYX PHARMACEUTICALS INC as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.